Skip to main content

CORRECTION article

Front. Psychiatry
Sec. Psychopharmacology
Volume 15 - 2024 | doi: 10.3389/fpsyt.2024.1523364

Corrigendum: Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice

Provisionally accepted
Kevin Mintz Kevin Mintz 1*Brinn Gammer Brinn Gammer 2Amanda Khan Amanda Khan 3,4Gretchen Shaub Gretchen Shaub 5Steven Levine Steven Levine 5Dominic Sisti Dominic Sisti 2
  • 1 Center for Biomedical Ethics, School of Medicine, Stanford University, Stanford, United States
  • 2 Department of Medical Ethics & Health Policy, University of Pennsylvania, Philadelphia, PA, United States
  • 3 Department of Psychiatry, University of California, San Francisco, San Francisco, CA, United States
  • 4 Sage Integrative Health, Berkeley, CA, United States
  • 5 Compass Pathways Ltd, London, United Kingdom

This article is a correction to:

  1. Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice

    1. Read original article

The final, formatted version of the article will be published soon.

    Corrigendum on: Mintz KT, Gammer B, Khan AJ, Shaub G, Levine S and Sisti D (2022) Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice. Front. Psychiatry 13:914458. doi: 10.3389/fpsyt.2022.914458 In the published article, there was an error in Table 2 as published. We wish to correct errors and clarify data presented in Table 2, pertaining to the prevalence of mental illness in several populations. Prevalence of Anxiety Disorders, Mood Disorders, and Schizophrenia in CP is in men. Prevalence of Anxiety in SCI should be 13.2-40% while prevalence of PTSD in SCI should be 7.1-26.6%. Prevalence of SUD in the D/deaf community reflects a population in outpatient psychiatric care and should be Anxiety Disorders -18.7%, Bipolar -3.7%, Impulse control disorders -15.8%, Substance Use Disorders -27.8%, and ADHD -11.2%. Prevalence of MDD, Anxiety Disorders, Schizophrenia, Alcohol Misuse, Psychoactive Substance Misuse, and Anorexia or Bulimia in blind populations is in patients older than 65. These adjustments do not change our paper's thesis and conclusion, and reflect a need for more general population-level data on the prevalence of mental illness across all disabilities. The corrected Table 2 and its caption "Disability community prevalence of mental disorders" appear below. We thank Jacob Kramer, an MSW student at Rhode Island College for helping bring these errors to our attention, particularly with regard to the D/deaf community. This error does not change the scientific conclusions of the article. The original article has been updated.

    Keywords: physical disability, Sensory disability, psychedelic therapies, Ethics, structural ableism in healthcare, Justice, inclusion in clinical research

    Received: 05 Nov 2024; Accepted: 22 Nov 2024.

    Copyright: © 2024 Mintz, Gammer, Khan, Shaub, Levine and Sisti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Kevin Mintz, Center for Biomedical Ethics, School of Medicine, Stanford University, Stanford, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.